1H-Indazole,5-bromo-7-ethyl-(9CI)

1H-Indazole,5-bromo-7-ethyl-(9CI) Suppliers list
Company Name: Sphinx Scientific Laboratory (Tianjin) Co., Ltd.  
Tel: 022-66211289-843 13672102692
Email: contact@sphinxpharm.com
Company Name: T&W GROUP  
Tel: 021-61551611 13296011611
Email: contact@trustwe.com
Company Name: Wuhan TCASChem Technology Co., Ltd.  
Tel: 027-86697669 13986148687
Email: sales@tcaschem.com
Company Name: Bide Pharmatech Ltd.  
Tel: 400-164-7117 18317119277
Email: product02@bidepharm.com
Company Name: ShangHai Angti Biotechnology Co., Ltd.  
Tel: 13764913901
Email: info@angtibio.com

1H-Indazole,5-bromo-7-ethyl-(9CI) manufacturers

1H-Indazole,5-bromo-7-ethyl-(9CI) Basic information
Product Name:1H-Indazole,5-bromo-7-ethyl-(9CI)
Synonyms:1H-Indazole,5-bromo-7-ethyl-(9CI);5-BROMO-7-ETHYL-1H-INDAZOLE;1H-Indazole, 5-broMo-7-ethyl-;5-bromo-7-ethyl-2H-indazole
CAS:635712-49-1
MF:C9H9BrN2
MW:225.09
EINECS:
Product Categories:ETHYL
Mol File:635712-49-1.mol
1H-Indazole,5-bromo-7-ethyl-(9CI) Structure
1H-Indazole,5-bromo-7-ethyl-(9CI) Chemical Properties
storage temp. Sealed in dry,Room Temperature
AppearanceOff-white to light brown Solid
Safety Information
HS Code 2933998090
MSDS Information
1H-Indazole,5-bromo-7-ethyl-(9CI) Usage And Synthesis
Synthesis
BenzenaMine, 4-broMo-2-ethyl-6-Methyl-

70598-49-1

1H-Indazole,5-bromo-7-ethyl-(9CI)

635712-49-1

5-bromo-3,7-dimethyl-1H-indazole

1031417-71-6

N-Bromosuccinimide (NBS, 2.66 g, 14.9 mmol) was slowly added to a solution of N,N-dimethylformamide (DMF, 50 mL) of 2-ethyl-6-methylaniline (2.03 g, 15 mmol) at 0 °C. The reaction mixture was stirred at room temperature for 10 min and then poured into saturated aqueous sodium chloride solution. The mixture was extracted with ethyl acetate (EtOAc) and the organic phase was washed twice with saturated aqueous sodium chloride solution, concentrated and purified by a Biotage fast chromatography system (40 M silica gel column, 15% ethyl acetate/heptane as eluent) to give 4-bromo-2-ethyl-6-methyl aniline as a reddish brown liquid (3.21 g, 100% yield). 4-Bromo-2-ethyl-6-methylaniline (3.21 g, 15 mmol) was dissolved in acetic acid (50 mL) and stirred for 3 h. 2M aqueous sodium nitrite (11 mL, 22.5 mmol) was added dropwise. The reaction mixture was stirred at room temperature overnight. The reaction solution was concentrated and the resulting solid was dissolved in ethyl acetate and washed three times with saturated aqueous sodium chloride solution. The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated, and the crude product was purified by a Biotage fast chromatography system (40 M silica gel column, 15-30% ethyl acetate/heptane gradient elution) to afford 5-bromo-7-ethyl-1H-indazole (1.11 g, 33% yield) and 5-bromo-3,7-dimethyl-1H-indazole (0.84 g, 25% yield), respectively. 5-Bromo-7-ethyl-1H-indazole (225 mg, 1.00 mmol), molybdenum hexacarbonyl (132 mg, 0.50 mmol), Herrmann's catalyst (trans-bis(acetic acid)bis[o-(di-o-tolylphosphino)benzyl]dipalladium, 46.9 mg, 0.05 mmol), and aqueous sodium carbonate (318 mg, 3.00 mmol, dissolved in 2 mL of water) were added to 1,4-dioxane (1.5 mL). The suspension was sealed and irradiated in a microwave reactor at 165 °C for 15 min (high absorption setting). Upon completion of the reaction, the reaction vial was opened, filtered through diatomaceous earth, washed with ethyl acetate and concentrated to afford the target compound (140 mg, 74% yield).

References[1] Journal of Medicinal Chemistry, 2012, vol. 55, # 2, p. 935 - 942
[2] Patent: WO2008/65508, 2008, A1. Location in patent: Page/Page column 31
Tag:1H-Indazole,5-bromo-7-ethyl-(9CI)(635712-49-1) Related Product Information
5-BROMO-6-METHOXY (1H)INDAZOLE 5-BROMOINDAZOLE-6-CARBOXYLIC ACID 5-broMo-1H-indole-7-carboxaMide 5-BROMO-6-METHYL INDOLE 1H-Pyrrolo[2,3-b]pyridine, 5-bromo-1-(phenylsulfonyl)- 5-Bromoindole-2-carboxylic acid methyl ester Ethyl bromide 5-BROMO-7-METHYL-1H-INDAZOLE 1H-Indazole,5-bromo-7-ethyl-(9CI)